Figure 3
From: Associations of metabolic syndrome and diabetes mellitus with 16-year survival after CABG
The actual survival 2 months–16 years postoperatively compared to that of the age-and sex-matched Finnish population (relative survival 1.00, n = 910). A. DM-/MetS- = patients with neither diabetes nor metabolic syndrome. DM-/MetS+ = patients with only metabolic syndrome. DM+ = diabetic patients. B. No DM = patients without diabetes. Non-insulin DM = diabetic patients without insulin treatment. Insulin DM = diabetic patients treated with insulin.